{"pmid":32341111,"title":"Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers.","text":["Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers.","Patients with COVID19 present a broad spectrum of clinical presentation. Whereas hypoxemia is the marker of severity, different strategies of management should be customised to five specific individual phenotypes. Many intubated patients present with phenotype 4, characterised by pulmonary hypoxic vasoconstriction, being associated with severe hypoxemia with \"normal\" (>40 mL.cm(-1) H20) lung compliance and likely represents pulmonary microvascular thrombosis. Phenotype 5 is often associated with high plasma procalcitonin, and has low pulmonary compliance, being a result of co-infection or acute lung injury after non-invasive ventilation. Identifying these clinical phenotypes and applying a personalised approach would benefit in optimisation of therapies and improving outcomes.","Eur Respir J","Rello, Jordi","Storti, Enrico","Belliato, Mirko","Serrano, Ricardo","32341111"],"abstract":["Patients with COVID19 present a broad spectrum of clinical presentation. Whereas hypoxemia is the marker of severity, different strategies of management should be customised to five specific individual phenotypes. Many intubated patients present with phenotype 4, characterised by pulmonary hypoxic vasoconstriction, being associated with severe hypoxemia with \"normal\" (>40 mL.cm(-1) H20) lung compliance and likely represents pulmonary microvascular thrombosis. Phenotype 5 is often associated with high plasma procalcitonin, and has low pulmonary compliance, being a result of co-infection or acute lung injury after non-invasive ventilation. Identifying these clinical phenotypes and applying a personalised approach would benefit in optimisation of therapies and improving outcomes."],"journal":"Eur Respir J","authors":["Rello, Jordi","Storti, Enrico","Belliato, Mirko","Serrano, Ricardo"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341111","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1183/13993003.01028-2020","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495128698880,"score":9.490897,"similar":[{"pmid":32440906,"title":"A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure.","text":["A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure.","Pulmonary complications are the most common clinical manifestations of coronavirus disease (COVID-19). From recent clinical observation, two phenotypes have emerged: a low elastance or L-type and a high elastance or H-type. Clinical presentation, pathophysiology, pulmonary mechanics, radiological and ultrasound findings of these two phenotypes are different. Consequently, the therapeutic approach also varies between the two. We propose a management algorithm that combines the respiratory rate and oxygenation index with bedside lung ultrasound examination and monitoring that could help determine earlier the requirement for intubation and other surveillance of COVID-19 patients with respiratory failure.","Can J Anaesth","Denault, Andre Y","Delisle, Stephane","Canty, David","Royse, Alistair","Royse, Colin","Serra, Ximena Cid","Gebhard, Caroline E","Couture, Etienne J","Girard, Martin","Cavayas, Yiorgos Alexandros","Peschanski, Nicolas","Langevin, Stephan","Ouellet, Paul","32440906"],"abstract":["Pulmonary complications are the most common clinical manifestations of coronavirus disease (COVID-19). From recent clinical observation, two phenotypes have emerged: a low elastance or L-type and a high elastance or H-type. Clinical presentation, pathophysiology, pulmonary mechanics, radiological and ultrasound findings of these two phenotypes are different. Consequently, the therapeutic approach also varies between the two. We propose a management algorithm that combines the respiratory rate and oxygenation index with bedside lung ultrasound examination and monitoring that could help determine earlier the requirement for intubation and other surveillance of COVID-19 patients with respiratory failure."],"journal":"Can J Anaesth","authors":["Denault, Andre Y","Delisle, Stephane","Canty, David","Royse, Alistair","Royse, Colin","Serra, Ximena Cid","Gebhard, Caroline E","Couture, Etienne J","Girard, Martin","Cavayas, Yiorgos Alexandros","Peschanski, Nicolas","Langevin, Stephan","Ouellet, Paul"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440906","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s12630-020-01704-6","keywords":["covid-19","and oxygenation index","lung ultrasound","respiratory failure","respiratory rate"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504768024579,"score":293.89105},{"pmid":32437877,"title":"Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.","text":["Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.","Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the clinical presentation of COVID-19 patients are not always like those of typical acute respiratory distress syndrome (ARDS) and can change over time. This manuscript aimed to provide brief guidance for respiratory management of COVID-19 patients before, during, and after mechanical ventilation, based on the recent literature and on our direct experience with this population. We identify that chest CT patterns in COVID-19 may be divided into three main phenotypes: 1) multiple, focal, possibly overperfused ground-glass opacities; 2) inhomogeneously distributed atelectasis; and 3) a patchy, ARDS-like pattern. Each phenotype can benefit from different treatments and ventilator settings. Also, peripheral macro- and microemboli are common, and attention should be paid to the risk of pulmonary embolism. We suggest use of personalized mechanical ventilation strategies based on respiratory mechanics and chest CT patterns. Further research is warranted to confirm our hypothesis.","Respir Physiol Neurobiol","Robba, Chiara","Robba, Chiara","Battaglini, Denise","Ball, Lorenzo","Patroniti, Nicolo'","Loconte, Maurizio","Brunetti, Iole","Vena, Antonio","Giacobbe, Daniele","Bassetti, Matteo","Rocco, Patricia Rieken Macedo","Pelosi, Paolo","32437877"],"abstract":["Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the clinical presentation of COVID-19 patients are not always like those of typical acute respiratory distress syndrome (ARDS) and can change over time. This manuscript aimed to provide brief guidance for respiratory management of COVID-19 patients before, during, and after mechanical ventilation, based on the recent literature and on our direct experience with this population. We identify that chest CT patterns in COVID-19 may be divided into three main phenotypes: 1) multiple, focal, possibly overperfused ground-glass opacities; 2) inhomogeneously distributed atelectasis; and 3) a patchy, ARDS-like pattern. Each phenotype can benefit from different treatments and ventilator settings. Also, peripheral macro- and microemboli are common, and attention should be paid to the risk of pulmonary embolism. We suggest use of personalized mechanical ventilation strategies based on respiratory mechanics and chest CT patterns. Further research is warranted to confirm our hypothesis."],"journal":"Respir Physiol Neurobiol","authors":["Robba, Chiara","Robba, Chiara","Battaglini, Denise","Ball, Lorenzo","Patroniti, Nicolo'","Loconte, Maurizio","Brunetti, Iole","Vena, Antonio","Giacobbe, Daniele","Bassetti, Matteo","Rocco, Patricia Rieken Macedo","Pelosi, Paolo"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437877","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.resp.2020.103455","keywords":["covid-19","sars-cov-2","mechanical ventilation","non-invasive ventilation","positive end expiratory pressure","prone position"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393748606977,"score":259.6064},{"pmid":32451626,"title":"Evaluation of fluid responsiveness during COVID-19 pandemic: what are the remaining choices?","text":["Evaluation of fluid responsiveness during COVID-19 pandemic: what are the remaining choices?","Non-protocolized fluid administration in critically ill patients, especially those with acute respiratory distress syndrome (ARDS), is associated with poor outcomes. Therefore, fluid administration in patients with Coronavirus disease (COVID-19) should be properly guided. Choice of an index to guide fluid management during a pandemic with mass patient admissions carries an additional challenge due to the relatively limited resources. An ideal test for assessment of fluid responsiveness during this pandemic should be accurate in ARDS patients, economic, easy to interpret by junior staff, valid in patients in the prone position and performed with minimal contact with the patient to avoid spread of infection. Patients with COVID-19 ARDS are divided into two phenotypes (L phenotype and H phenotype) according to their lung compliance. Selection of the proper index for fluid responsiveness varies according to the patient phenotype. Heart-lung interaction methods can be used only in patients with L phenotype ARDS. Real-time measures, such a pulse pressure variation, are more appropriate for use during this pandemic compared to ultrasound-derived measures, because contamination of the ultrasound machine can spread infection. Preload challenge tests are suitable for use in all COVID-19 patients. Passive leg raising test is relatively better than mini-fluid challenge test, because it can be repeated without overloading the patient with fluids. Trendelenburg maneuver is a suitable alternative to the passive leg raising test in patients with prone position. If a cardiac output monitor was not available, the response to the passive leg raising test could be traced by measurement of the pulse pressure or the perfusion index. Preload modifying maneuvers, such as tidal volume challenge, can also be used in COVID-19 patients, especially if the patient was in the gray zone of other dynamic tests. However, the preload modifying maneuvers were not extensively evaluated outside the operating room. Selection of the proper test would vary according to the level of healthcare in the country and the load of admissions which might be overwhelming. Evaluation of the volume status should be comprehensive; therefore, the presence of signs of volume overload such as lower limb edema, lung edema, and severe hypoxemia should be considered beside the usual indices for fluid responsiveness.","J Anesth","Hasanin, Ahmed","Mostafa, Maha","32451626"],"abstract":["Non-protocolized fluid administration in critically ill patients, especially those with acute respiratory distress syndrome (ARDS), is associated with poor outcomes. Therefore, fluid administration in patients with Coronavirus disease (COVID-19) should be properly guided. Choice of an index to guide fluid management during a pandemic with mass patient admissions carries an additional challenge due to the relatively limited resources. An ideal test for assessment of fluid responsiveness during this pandemic should be accurate in ARDS patients, economic, easy to interpret by junior staff, valid in patients in the prone position and performed with minimal contact with the patient to avoid spread of infection. Patients with COVID-19 ARDS are divided into two phenotypes (L phenotype and H phenotype) according to their lung compliance. Selection of the proper index for fluid responsiveness varies according to the patient phenotype. Heart-lung interaction methods can be used only in patients with L phenotype ARDS. Real-time measures, such a pulse pressure variation, are more appropriate for use during this pandemic compared to ultrasound-derived measures, because contamination of the ultrasound machine can spread infection. Preload challenge tests are suitable for use in all COVID-19 patients. Passive leg raising test is relatively better than mini-fluid challenge test, because it can be repeated without overloading the patient with fluids. Trendelenburg maneuver is a suitable alternative to the passive leg raising test in patients with prone position. If a cardiac output monitor was not available, the response to the passive leg raising test could be traced by measurement of the pulse pressure or the perfusion index. Preload modifying maneuvers, such as tidal volume challenge, can also be used in COVID-19 patients, especially if the patient was in the gray zone of other dynamic tests. However, the preload modifying maneuvers were not extensively evaluated outside the operating room. Selection of the proper test would vary according to the level of healthcare in the country and the load of admissions which might be overwhelming. Evaluation of the volume status should be comprehensive; therefore, the presence of signs of volume overload such as lower limb edema, lung edema, and severe hypoxemia should be considered beside the usual indices for fluid responsiveness."],"journal":"J Anesth","authors":["Hasanin, Ahmed","Mostafa, Maha"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451626","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s00540-020-02801-y","keywords":["covid-19","fluid responsiveness","heart-lung interaction","pandemic","passive leg raising test","septic shock"],"locations":["Trendelenburg"],"topics":["Prevention"],"weight":1,"_version_":1667881798517915648,"score":230.71439},{"pmid":32341785,"pmcid":"PMC7180634","title":"Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence).","text":["Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence).","The novel coronavirus disease 2019 (COVID-19) is spreading in Japan. We have collected a total of 26 patients with COVID-19 who required extracorporeal membranous oxygenation (ECMO). The available data from the first 14 cases demonstrated that the median age of patients was 71 and the median PaO2/FIO2 ratio, positive end-expiratory pressure, mean airway pressure, and lung compliance were 70, 15 cmH2O, 21 cmH2O, and 28 mL/cmH2O, respectively. Median serum KL-6 level was 333 U/mL. Consequently, 16 (62%) out of the 26 have been weaned off and 6 (26%) have been extubated and on rehabilitation, while the other 10 (38%) remain on ECMO. There seemed to be two phenotypes of COVID-19: one with impaired lung compliance and one with preserved lung compliance. The latter phenotype was likely to be favored from the use of ECMO. Further investigation is necessary to clasrify the optimal use of ECMO in patients with COVID-19.","J Intensive Care","32341785"],"abstract":["The novel coronavirus disease 2019 (COVID-19) is spreading in Japan. We have collected a total of 26 patients with COVID-19 who required extracorporeal membranous oxygenation (ECMO). The available data from the first 14 cases demonstrated that the median age of patients was 71 and the median PaO2/FIO2 ratio, positive end-expiratory pressure, mean airway pressure, and lung compliance were 70, 15 cmH2O, 21 cmH2O, and 28 mL/cmH2O, respectively. Median serum KL-6 level was 333 U/mL. Consequently, 16 (62%) out of the 26 have been weaned off and 6 (26%) have been extubated and on rehabilitation, while the other 10 (38%) remain on ECMO. There seemed to be two phenotypes of COVID-19: one with impaired lung compliance and one with preserved lung compliance. The latter phenotype was likely to be favored from the use of ECMO. Further investigation is necessary to clasrify the optimal use of ECMO in patients with COVID-19."],"journal":"J Intensive Care","date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341785","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1186/s40560-020-00445-4","keywords":["acute respiratory failure","compliance","kl-6","mechanical ventilation","prognosis"],"locations":["Japan","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Treatment"],"weight":1,"_version_":1666138495806078977,"score":226.29515},{"pmid":32466289,"title":"Cellular Metabolic Profiling of CrFK Cells Infected with Feline Infectious Peritonitis Virus Using Phenotype Microarrays.","text":["Cellular Metabolic Profiling of CrFK Cells Infected with Feline Infectious Peritonitis Virus Using Phenotype Microarrays.","Feline infectious peritonitis (FIP) is a fatal feline immune-mediated disease caused by feline infectious peritonitis virus (FIPV). Little is known about the biological pathways associated in FIP pathogenesis. This is the first study aiming to determine the phenotypic characteristics on the cellular level in relation to specific metabolic pathways of importance to FIP pathogenesis. METHODS: The internalization of type II FIPV WSU 79-1146 in Crandell-Rees Feline Kidney (CrFK) cells was visualized using a fluorescence microscope, and optimization prior to phenotype microarray (PM) study was performed. Then, four types of Biolog Phenotype MicroArray plates (PM-M1 to PM-M4) precoated with different carbon and nitrogen sources were used to determine the metabolic profiles in FIPV-infected cells. RESULTS: The utilization of palatinose was significantly low in FIPV-infected cells; however, there were significant increases in utilizing melibionic acid, L-glutamine, L-glutamic acid and alanyl-glutamine (Ala-Gln) compared to non-infected cells. CONCLUSION: This study has provided the first insights into the metabolic profiling of a feline coronavirus infection in vitro using PMs and deduced that glutamine metabolism is one of the essential metabolic pathways for FIPV infection and replication. Further studies are necessary to develop strategies to target the glutamine metabolic pathway in FIPV infection.","Pathogens","Ng, Shing Wei","Selvarajah, Gayathri Thevi","Cheah, Yoke Kqueen","Mustaffa Kamal, Farina","Omar, Abdul Rahman","32466289"],"abstract":["Feline infectious peritonitis (FIP) is a fatal feline immune-mediated disease caused by feline infectious peritonitis virus (FIPV). Little is known about the biological pathways associated in FIP pathogenesis. This is the first study aiming to determine the phenotypic characteristics on the cellular level in relation to specific metabolic pathways of importance to FIP pathogenesis. METHODS: The internalization of type II FIPV WSU 79-1146 in Crandell-Rees Feline Kidney (CrFK) cells was visualized using a fluorescence microscope, and optimization prior to phenotype microarray (PM) study was performed. Then, four types of Biolog Phenotype MicroArray plates (PM-M1 to PM-M4) precoated with different carbon and nitrogen sources were used to determine the metabolic profiles in FIPV-infected cells. RESULTS: The utilization of palatinose was significantly low in FIPV-infected cells; however, there were significant increases in utilizing melibionic acid, L-glutamine, L-glutamic acid and alanyl-glutamine (Ala-Gln) compared to non-infected cells. CONCLUSION: This study has provided the first insights into the metabolic profiling of a feline coronavirus infection in vitro using PMs and deduced that glutamine metabolism is one of the essential metabolic pathways for FIPV infection and replication. Further studies are necessary to develop strategies to target the glutamine metabolic pathway in FIPV infection."],"journal":"Pathogens","authors":["Ng, Shing Wei","Selvarajah, Gayathri Thevi","Cheah, Yoke Kqueen","Mustaffa Kamal, Farina","Omar, Abdul Rahman"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466289","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/pathogens9050412","keywords":["crfk cells","cellular metabolism","feline infectious peritonitis virus","glutamine","metabolic profiling","phenotype microarray"],"locations":["Feline","feline"],"e_drugs":["isomaltulose","Glutamic Acid","Glutamine","melibionic acid","alanylglutamine","Nitrogen","Carbon"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668167110092652544,"score":198.00075}]}